2026-04-25T12:24:58Z
https://www.pub.unibl.org/oai
oai:pub.unibl.org:39950
2026-03-26T04:43:22Z
Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal carcinoma
/unibl/author/Saša Jungić
https://www.unibl.org/sr-lat/fis/zaposlen/3255-biljana-tubic
/unibl/author/Radoslav Gajanin
/unibl/author/Zdenka Gojković
/unibl/author/Ivanka Rakita
2017-06
Academic Article
text
255
249
/unibl/sci/idNaucniRad:13156
616-006::616.348/.351-006-085
https://dx.doi.org/10.2298/VSP150513173J
VOJNOSANITETSKI PREGLED
0042-8450
VOJNOSANITETSKI PREGLED
0042-8450
http://www.doiserbia.nb.rs/img/doi/0042-8450/2016%20OnLine-First/0042-84501600173J.pdf
S. Jungić, B. Tubić, R. Gajanin, Z. Gojković, I. Rakita, Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal carcinoma, VOJNOSANITETSKI PREGLED, Vol. 3, No. 74, pp. 249 - 255, Jun, 2017